• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / Media / About / SANE Vax Press Releases / Open letter to EMA re: HPV vaccine safety

Open letter to EMA re: HPV vaccine safety

April 24, 2016 By Norma 9 Comments

SaneVax-Featured

Note from SaneVax: Apparently medical professionals, scientists, vaccine safety advocates and the general public are not satisified with the recent EMA conclusion regarding HPV vaccine safety. They are not willing to accept the fact that the written statement on HPV vaccine safety issued by the European Medicines Agency spent more time attempting to discredit those who filed medically documented questions than it did dealing with an honest evaluation of the safety concerns being raised around the world after Gardasil and Cervarix administration. Medical consumers are no longer willing to accept the word of purported experts unless it is backed up by sound science.

Therefore, the following letter was just emailed to over 120 European Medicines Agency representatives with 446 signatures representing HPV vaccine survivors from over 30 countries requesting scientifically documented answers to the attached questions and an open public meeting with participants from both sides of the debate invited to discuss HPV vaccine safety.

Open letter to EMA regarding HPV vaccine safety

24 April 2016

Dear EMA representatives:

I am sure you are all aware of the European Medicines Agency’s recent ‘investigation’ into HPV vaccine safety. I am also certain you understand that the investigation was cursory at best and most definitely not designed to uncover any real problem that may exist with HPV vaccines. The arbitrary and most likely pre-ordained conclusion reached must not go unchallenged. Public health and safety is at stake, particularly when many scientists around the world follow your lead.

One prime example is a recent study published in a Canadian medical journal entitled, “Adverse events following HPV vaccination, Alberta 2006-2014.” Despite the fact that this study uncovered information indicating 1 in 10 Gardasil users were either admitted to a hospital or an emergency room within 42 days of injection, the conclusion was “Rates of AEFI after HPV immunization in Alberta are low and consistent with types of events seen elsewhere.”

With all due respect, we believe the EMA would find it extremely difficult to locate any country where 1 in 10 previously healthy teens were admitted to hospitals and/or emergency rooms after any given event, including receipt of a vaccine.

With that in mind, representatives from several countries got together over the last few months to compose a letter asking the questions the recent investigation neglected to address.

Initially, the attached list of questions was meant to be sent directly to those people in charge of the EMA’s HPV vaccine safety investigation. However, because of the near universal response to inquiries about HPV vaccines worldwide, we came to understand that a letter sent directly to EMA representatives would most likely not elicit any meaningful response.

Therefore, this letter with both attachments will be published via the SaneVax website and be free for distribution by anyone who cares to do so. The primary purpose is to make all representatives of the EMA well aware of the fact that every action you make is being closely scrutinized by not only those injured and their families, but also medical and scientific professionals around the globe.

The secondary goal of open publication is to show all who are concerned about the safety profile of HPV vaccines that they are not alone. Medical professionals, scientists and medical consumers will no longer tolerate attempts to discredit independent research based on the fact that their research and experience does not fall in line with theories put forth by general consensus supported only by questionable research.

On April 15, 2016, the EMA published a statement online entitled, “Listening to the public’s views on the safety of medicines” where Deputy Executive Director, Noël Wathion, states:

“Public hearings will enrich the scientific decision-making process on the safety of medicines. Although we have many years of experience in involving patients and healthcare professionals in our work, public hearings are a new concept for EMA as they will open up the process of assessing medicines in the EU to the wider public for the first time.”

Public hearings will be held on a case-by-case basis, where the Committee determines that collecting the views of the public would bring added value to its review.

The EMA’s statements and decisions regarding HPV vaccines impact people around the globe. Society cannot wait decades to determine whether HPV vaccines will actually impact cancer rates if the “1 in 10” figure put forth in the Canadian study is anywhere near accurate for other countries.

Therefore, it is imperative for the EMA to meet with and seriously take into account the views of scientists, medical professionals and citizens who are dealing with the impact of HPV vaccines on a daily basis under real world conditions. An open public hearing is the ideal format for a discussion on the real-world consequences of HPV vaccine utilization.

The undersigned (complete list attached) request scientifically documented answers to the attached questions be provided within the next 30 days and an open public meeting as described above to be held before the end of 2016.

Thank you in advance for your attention to this critical public health issue.

Sincerely,

Steve Hinks, Press Officer of the UK Association of HPV Vaccine Injured Daughters (AHVID) and SaneVax Ambassador

Freda Birrell, Chairman of AHVID, representing 285 families whose lives have been severely impacted by HPV vaccines

Karsten Viborg, Director, Chairman, National HPV side effect group in Denmark on behalf of over 5,000 affected families

Alicia Capilla Lanagrán, President of the AAVP, representing over 50 families impacted in Spain

Kiva Murphy, REGRET member on behalf of over 300 affected families in Ireland

Monica Leon Del Rio, President of Rebuilding Hope Association on behalf of 559 families severely affected in Colombia.

Stephen Tunley, Board of Directors SaneVax Inc., on behalf of 50 severely affected families in Australia

Gayle Dickson, Founder of Gardasil Awareness New Zealand, on behalf of over 600 families affected in NZ

Norma Erickson, President of SaneVax Inc., on behalf of 1679 families who reported disabilities and deaths after HPV vaccines in the United States VAERS system and the 446 signatories from over 30 countries in the attached file.

ATTACHMENTS:

Signatures for EMA letter

Questions to EMA

Read the questions to EMA in Spanish here.

Read the questions sent to EMA in Italian at the end of this article.

Read this letter in Croatian here.

EMA Response

Mr. Steve Hinks received the following response from the European Medicines Agency before noon on the 25th of April 2016:

Dear Mr. Hinks,
We hereby acknowledge receipt of your letter of 24 April 2016 and the questions to EMA contained therein as well as your earlier e-mail correspondence of 18 April to Nathalie Bere. 
I confirm that we will do our utmost to respond to your queries within 30 days as you request.
Yours sincerely
Isabelle Moulon
Head of Patients and Healthcare Professionals Department
Stakeholder and Communication Division
European Medicines Agency
30 Churchill Place | Canary Wharf | London E14 5EU | United Kingdom

Related

Filed Under: Europe, European, HPV, SANE Vax Press Releases Tagged With: European Medicines Agency, HPV vaccine safety

Comments

  1. Brian Aylward says

    June 2, 2016 at 1:02 am

    Are you going to publish the response you have received from the EMA?

    Reply
    • admin says

      June 2, 2016 at 2:10 am

      Yes, it will be published as soon as possible.

      Reply

Trackbacks

  1. European Medicines Agency Caves to Big Pharma – Brushes Aside HPV Vaccine Safety Issues | Health Exchange says:
    April 27, 2016 at 6:56 pm

    […] by SaneVax.org […]

    Reply
  2. Open letter to EMA re: HPV vaccine safety | The Liberty Beacon says:
    April 27, 2016 at 11:50 pm

    […] Signatures for EMA letter […]

    Reply
  3. Otvoreno pismo Europskoj agenciji za lijekove (EMA) – predmet: sigurnost HPV cjepiva | Cijepljenje.info says:
    April 28, 2016 at 2:06 pm

    […] Izvor: https://sanevax.org/open-letter-ema-hpv-vaccine-safety/ […]

    Reply
  4. Nordic Cochrane Centre podnosi pritužbu europskoj pravobraniteljici zbog nepravilnosti u radu Europske agencije za lijekove u procjeni sigurnosti HPV cjepiva | Cijepljenje.info says:
    October 20, 2016 at 7:06 am

    […] 4. Open letter to EMA re: HPV vaccine safety […]

    Reply
  5. Help stop a bad vaccine bill in the California Legislature! - The Weston A. Price Foundation says:
    April 12, 2023 at 2:30 am

    […] and complaints for injury and death have been filed over HPV vaccines in the United States, France, […]

    Reply
  6. Support S4002 To Protect Children From Certain Mandatory Vaccinations As A Condition Of School Attendance In New Jersey - Deadline 8/24/23 - The Weston A. Price Foundation says:
    August 24, 2023 at 3:29 pm

    […] and complaints for injury and death have been filed over HPV vaccines in the United States, France, […]

    Reply
  7. Help stop a bad vaccine bill in the California Legislature TODAY! - The Weston A. Price Foundation says:
    September 12, 2023 at 3:28 pm

    […] and complaints for injury and death have been filed over HPV vaccines in the United States, France, […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Gardasil: The decision I will always regret

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

DANGEROUS GARDASIL ‘IT IS CONTAMINATED!’ SANEVAX.ORG

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2025 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in

 

Loading Comments...